Privia Health Group’s (PRVA) “Overweight” Rating Reiterated at Stephens

Stephens restated their overweight rating on shares of Privia Health Group (NASDAQ:PRVA) in a report published on Thursday morning,Benzinga reports. Stephens currently has a $26.00 price objective on the stock.

Several other brokerages have also commented on PRVA. KeyCorp started coverage on Privia Health Group in a research note on Friday, October 11th. They issued an “overweight” rating and a $23.00 price target on the stock. Barclays upped their target price on shares of Privia Health Group from $19.00 to $21.00 and gave the company an “equal weight” rating in a research report on Friday, November 8th. Macquarie initiated coverage on shares of Privia Health Group in a research report on Monday, December 16th. They set an “outperform” rating and a $25.00 price target for the company. JPMorgan Chase & Co. boosted their price target on shares of Privia Health Group from $27.00 to $28.00 and gave the company an “overweight” rating in a research note on Friday, November 29th. Finally, Truist Financial lifted their target price on shares of Privia Health Group from $24.00 to $27.00 and gave the company a “buy” rating in a report on Friday, November 8th. Two analysts have rated the stock with a hold rating, thirteen have given a buy rating and two have given a strong buy rating to the company. Based on data from MarketBeat, Privia Health Group currently has a consensus rating of “Buy” and an average target price of $24.88.

Privia Health Group Stock Performance

PRVA opened at $19.64 on Thursday. The stock has a market capitalization of $2.36 billion, a PE ratio of 196.42, a P/E/G ratio of 5.45 and a beta of 0.83. Privia Health Group has a one year low of $15.92 and a one year high of $23.78. The business’s 50 day moving average price is $20.62 and its 200 day moving average price is $19.28.

Institutional Investors Weigh In On Privia Health Group

Several large investors have recently bought and sold shares of the stock. Canada Pension Plan Investment Board acquired a new stake in shares of Privia Health Group in the 2nd quarter valued at $26,000. GAMMA Investing LLC increased its holdings in Privia Health Group by 98.7% in the third quarter. GAMMA Investing LLC now owns 1,701 shares of the company’s stock valued at $31,000 after buying an additional 845 shares during the last quarter. Signaturefd LLC increased its holdings in Privia Health Group by 46.3% in the second quarter. Signaturefd LLC now owns 1,978 shares of the company’s stock valued at $34,000 after buying an additional 626 shares during the last quarter. Quarry LP raised its stake in Privia Health Group by 344.6% in the third quarter. Quarry LP now owns 3,268 shares of the company’s stock valued at $60,000 after buying an additional 2,533 shares in the last quarter. Finally, KBC Group NV lifted its holdings in Privia Health Group by 34.6% during the 3rd quarter. KBC Group NV now owns 3,385 shares of the company’s stock worth $62,000 after buying an additional 871 shares during the last quarter. Hedge funds and other institutional investors own 94.48% of the company’s stock.

Privia Health Group Company Profile

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.